Placebo, n = 80 | Naproxcinod 750 mg qd, n = 108 | Naproxcinod 750 mg bid, n = 116 | Naproxcinod 1125 mg bid, n = 124 | Rofecoxib 25 mg qd, n = 115 | |
---|---|---|---|---|---|
Baseline | |||||
N | 80 | 108 | 116 | 124 | 115 |
Mean (SD) | 138.5 (18.81) | 136.8 (17.69) | 135.4 (16.24) | 136.5 (17.60) | 136.4 (17.06) |
Week 6 | |||||
N | 70 | 97 | 105 | 114 | 100 |
Mean (SD) | 133.8 (16.15) | 135.2 (17.56) | 133.4 (16.21) | 129.0 (17.27) | 139.4 (19.45) |
Change from baseline to Week 6 | |||||
N | 70 | 97 | 105 | 114 | 100 |
Mean (SD) | −4.5 (15.83) | −1.8 (13.38) | −1.8 (14.91) | −6.5 (14.57) | 3.1 (12.92) |